Cnattingius S, Signorello LB, Anneren G, et al. Caffeine intake and the risk
of first trimester spontaneous abortion. N Engl J Med 2000;343:1839–45.
Clarren SK, Smith DW. The fetal alcohol syndrome. N Engl J Med
1978;298:1063–7.
Jones KL. Fetal alcohol syndrome. Pediatr Rev
1986;8:122–6.
Streissguth AP, Aase JM, Clarren SK, et al. Fetal alcohol syndrome in
adolescents and adults. JAMA 1991;265:1961–7.
Stratton K, Howe C, Battaglia F, eds. Fetal Alcohol Syndrome: Diagnosis,
Epidemiology, Prevention and Treatment. Washington, DC: National Academy Press;
1996:4–21.
Gold S, Sherry L. Hyperactivity, learning disabilities and alcohol. J
Learn Disabil 1984;17:3–6.
Mills JL, Granbard BI, Harley EE, et al. Maternal alcohol consumption and
birth weight: how much drinking in pregnancy is safe? JAMA
1984;252:1875–9.
Kaminski M. Maternal alcohol consumption and its relation to the outcome of
pregnancy and child development at 18 months. Int J Epidemiol 1992;21(suppl
1):S79–81.
Paul M, ed. Occupational and Environmental Reproductive Hazards. A Guide
for Clinicians. Baltimore, MD: Williams & Wilkins, 1993:xviii.
Lalande NM, Hetu R, Lambert J. Is occupational noise exposure during pregnancy
a risk factor of damage to the auditory system of the fetus? Am J Ind Med
1986;10:427–35.
Shaw GM, Todoroff K, Finnell RH, Lammer EJ. Spina bifida phenotypes in infants
or fetuses of obese mothers. Teratology 2000;61:376–81.
MRC Vitamin Study Research Group. Prevention of neural tube defects: results
of the Medical Research Council Vitamin Study. Lancet 1991;338:131–7.
Czeizel AE, Dudás I. Prevention of the first occurrence of neural-tube
defects by periconceptional vitamin supplementation. N Engl J Med
1992;327:1832–5.
Forrest JD. Epidemiology of unintended pregnancy and contraceptive use. Am
J Obstet Gynecol. 1994;170:1485–9.
Moore KL. Formulation of the trilaminar embryo. In: The Developing
Human. Philadelphia, PA: WB Saunders Co., 1988:55–64.
Centers for Disease Control and Prevention. Use of folic acid for prevention
of spina bifida and other neural tube defects: 1983–1991. MMWR
1991;40:513–6.
Velie EM, Block G, Shaw GM, et al. Maternal supplemental and dietary zinc
intake and the occurrence of neural tube defects in California. Am J Epidemiol
1999;150:605–16.
Hambidge M, Hackshaw A, Wald N. Neural tube defects and serum zinc. Br J
Obstet Gynaecol 1993;100:746–9.
Botto LD, Mulinare J, Erickson JD. Occurrence of congenital heart defects in
relation to maternal mulitivitamin use. Am J Epidemiol 2000;151:878–84.
Botto LD, Khoury MJ, Mulinare J, Erickson JD. Periconceptional multivitamin
use and the occurrence of conotruncal heart defects: results from a population-based,
case-control study. Pediatrics 1996;98:911–7.
Czeizel AE. Reduction of urinary tract and cardiovascular defects by
periconceptional multivitamin supplementation. Am J Med Genet
1996;62:179–83.
Werler MM, Hayes C, Louik C, et al. Multivitamin supplementation and risk of
birth defects. Am J Epidemiol 1999;150:675–82.
Preston-Martin S, Pogoda JM, Mueller BA, et al. Prenatal vitamin
supplementation and risk of childhood brain tumors. Int J Cancer Suppl
1998;11:17–22.
Rothman KJ, Moore LL, Singer MR, et al. Teratogenicity of high vitamin A
intake. N Engl J Med 1995;333:1369–73.
Mastroiacovo P, Mazzone T, Addis A, et al. High vitamin A intake in early
pregnancy and major malformations: a multicenter prospective controlled study.
Teratology 1999;59:7–11.